Free Trial

Lichen China (LICN) Competitors

Lichen China logo
$3.38 -0.36 (-9.63%)
Closing price 04/10/2025 04:00 PM Eastern
Extended Trading
$3.43 +0.05 (+1.48%)
As of 04/10/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LICN vs. LIFW, RVYL, QH, SPPL, MSPR, GMHS, INTJ, KRKR, GRNQ, and LDWY

Should you be buying Lichen China stock or one of its competitors? The main competitors of Lichen China include MSP Recovery (LIFW), Ryvyl (RVYL), Quhuo (QH), Simpple (SPPL), MSP Recovery (MSPR), Gamehaus (GMHS), Intelligent Group (INTJ), 36Kr (KRKR), Greenpro Capital (GRNQ), and Lendway (LDWY). These companies are all part of the "business services" industry.

Lichen China vs.

Lichen China (NASDAQ:LICN) and MSP Recovery (NASDAQ:LIFW) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Lichen China and MSP Recovery both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Lichen ChinaN/AN/A
MSP RecoveryN/AN/A

In the previous week, Lichen China had 1 more articles in the media than MSP Recovery. MarketBeat recorded 1 mentions for Lichen China and 0 mentions for MSP Recovery. Lichen China's average media sentiment score of 1.87 beat MSP Recovery's score of 0.00 indicating that Lichen China is being referred to more favorably in the media.

Company Overall Sentiment
Lichen China Very Positive
MSP Recovery Neutral

Lichen China has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.38, suggesting that its share price is 338% less volatile than the S&P 500.

Lichen China has a net margin of 0.00% compared to MSP Recovery's net margin of -906.67%. Lichen China's return on equity of 0.00% beat MSP Recovery's return on equity.

Company Net Margins Return on Equity Return on Assets
Lichen ChinaN/A N/A N/A
MSP Recovery -906.67%-6.25%-2.39%

3.8% of MSP Recovery shares are owned by institutional investors. 86.5% of MSP Recovery shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Lichen China has higher revenue and earnings than MSP Recovery.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lichen China$41.93M0.05$8.34MN/AN/A
MSP Recovery$10.73M0.82-$56.35M-$142.50-0.01

Summary

Lichen China beats MSP Recovery on 8 of the 11 factors compared between the two stocks.

Remove Ads
Get Lichen China News Delivered to You Automatically

Sign up to receive the latest news and ratings for LICN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LICN vs. The Competition

MetricLichen ChinaManagement consulting services IndustryFinance SectorNASDAQ Exchange
Market Cap$2.03M$2.00B$10.43B$7.37B
Dividend YieldN/A2.83%5.81%4.27%
P/E RatioN/A10.2021.1317.55
Price / Sales0.0516.9424.4489.70
Price / Cash0.1762.1317.6134.64
Price / Book1.465.632.493.81
Net Income$8.34M$106.41M$1.03B$247.05M
7 Day Performance-7.40%-3.27%-3.72%-3.51%
1 Month Performance-27.62%-3.48%487.81%-8.43%
1 Year Performance-98.42%24.36%529.67%-6.46%

Lichen China Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LICN
Lichen China
N/A$3.38
-9.6%
N/A-98.4%$2.03M$41.93M0.00390Positive News
Gap Down
LIFW
MSP Recovery
N/A$1.38
-2.8%
N/A-96.5%$9.06M$10.73M-0.013
RVYL
Ryvyl
1.7546 of 5 stars
$0.99
-6.6%
N/A-63.9%$8.85M$63.53M-0.1250Analyst Revision
Gap Down
QH
Quhuo
0.8733 of 5 stars
$1.43
+0.7%
N/A+111.7%$8.82M$3.59B0.00680Positive News
SPPL
Simpple
0.1052 of 5 stars
$0.53
+5.2%
N/A-44.1%$8.60M$4.70M0.0034
MSPR
MSP Recovery
N/A$1.27
-8.0%
N/AN/A$8.33M$10.73M-0.013News Coverage
GMHS
Gamehaus
N/A$1.83
+9.6%
N/AN/A$8.30M$145.24M0.00N/APositive News
INTJ
Intelligent Group
N/A$0.63
-3.1%
N/A-70.3%$8.20M$22.76M0.0017Gap Down
KRKR
36Kr
1.7517 of 5 stars
$3.99
-6.3%
N/A-43.9%$7.78M$231.07M-0.67570
GRNQ
Greenpro Capital
0.8359 of 5 stars
$0.89
-2.9%
N/A-26.7%$6.74M$2.73M-1.0360Earnings Report
Gap Down
LDWY
Lendway
0.6349 of 5 stars
$3.76
+0.3%
N/A-39.9%$6.66M$31.58M-1.9030
Remove Ads

Related Companies and Tools


This page (NASDAQ:LICN) was last updated on 4/11/2025 by MarketBeat.com Staff
From Our Partners